Gatifloxacin induces augmented insulin release and intracellular insulin depletion of pancreatic islet cells

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 4, 2007, Pages 644-647

  Tomita, Takashi ^a   Onishi, Mariko ^b   Sato, Eiji ^c   Kimura, Yasuhiro ^a,b   Kihira, Kenji ^a,b  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Fluoroquinolone; Gatifloxacin; Hyperglycemia; Hypoglycemia; Insulin; Pancreatic islet cell

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONYLUREA;

ANIMAL CELL; ARTICLE; DRUG MECHANISM; HOMEOSTASIS; HYPOGLYCEMIA; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET CELL;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL LINE; CELL SURVIVAL; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROQUINOLONES; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; KINETICS; MESOCRICETUS;

EID: 34147102462     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.644     Document Type: Article

References (22)

1. Grasela D. M., Clin. Infect. Dis., 31 (Suppl. 2), S51-S58 (2000).
2. Fish D. N., North D. S., Pharmacotherapy, 21, 35-59 (2001).
3. Baker S. E., Hangii M. C., Ann. Pharmacother., 36, 1722-1726 (2002).
4. Donaldson A. R., Vandiver J. R., Finch C. K., Ann. Pharmacother., 38, 602-605 (2004).
5. Beste L. A., Mersfelder T. L., Am. J. Geriatr. Pharmacother., 3, 262-265 (2005).
6. Frothingham R., Clin. Infect. Dis., 41, 1269-1276 (2005).
7. Park-Wyllie L. Y., Juurlink D. N., Kopp A., Shah B. R., Stukel T. A., Stumpo C., Dresser L., Low D. E., Mamdani M. M., N. Engl. J. Med., 354, 1352-1361 (2006).
8. Tamayama T., Tanaka Y., Saito A., Jpn. J. Chemother., 52, 521-529 (2004).
9. Takahashi M., Echizen H., Takahashi K., Shimada S., Aoyama N., Izumi T., Ther. Drug Monit., 24, 492-496 (2002).
10. Sernyak M. J., Leslie D. L., Alarcon R. D., Losonczy M. F., Rosenheck R., Am. J. Psychiatry, 159, 561-566 (2002).
11. Friedrich L. V., Dougherty R., Pharmacotherapy, 24, 1807-1812 (2004).
12. Sakurai I., Yoshida M., Ishida Y., Matsumoto F., Takahashi T., Morita M., Ueda Y., Jpn. J. Chemother., 44, 798-803 (1996).
13. Santerre R. F., Cook R. A., Crisel R. M., Sharp J. D., Schmidt R. J., Williams D. C., Wilson C. P., Proc. Natl. Acad. Sci. U.S.A., 78, 4339-4343 (1981).
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
15. Scudiero D. A., Shoemaker R. H., Paull K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D., Boyd M. R., Cancer Res., 48, 4827-4833 (1988).
16. Maeda N., Tamagawa T., Niki I., Miura H., Ozawa K., Watanabe G., Nonogaki K., Uemura K., Iguchi A., Br. J. Pharmacol., 117, 372-376 (1996).
17. Zunkler B. J., Wos M., Life Sci., 73, 429-435 (2003).
18. Saraya A., Yokokura M., Gonoi T., Seino S., Eur. J. Pharmacol., 497, 111-117 (2004).
19. Idesawa A., Izawa S., Kosei N., Machida M., Toriuni C., Yuasa R., Komuro M., Nagatsu Y., Ishida R., Ohkubo H., Uchida H., Jpn. J. Chemother., 47, 131-140 (1999).
20. Ambrose P. G., Bhavnani S. M., Cirincione B. B., Piedmonte M., Grasela T. H., J. Antimicrob. Chemother., 52, 435-440 (2003).
21. Blommel A. L., Lutes R. A., Ann. Pharmacother., 39, 1349-1352 (2005).
22. Yamada C., Nagashima K., Takahashi A., Ueno H., Kawasaki Y., Yamada Y., Seino Y., Inagaki N., Eur. J. Pharmacol., 553, 67-72 (2006).